Navigation Links
FDA Clears Laser for all Critical Steps in Cataract Surgery: Center For Sight Performs the Most LENSAR Laser Procedures in U.S.
Date:12/16/2012

Sarasota, FL (PRWEB) December 16, 2012

The next generation of refractive cataract surgery reached another significant milestone when the United States Food and Drug Administration (FDA) issued clearance for the LENSAR Laser System to perform corneal incisions – the key step to gaining access into the clouded lens of the eye. The clearance means that patients considering the laser procedure for the removal of their cataracts have another critical tool to help optimize safety, satisfaction and outcomes in connection with their surgery.

The corneal incision made with the laser offers surgeons the ability to execute tiny, ultra-precise, self-sealing incisions. In August, the LENSAR laser was approved by the FDA to create the perfectly round and centered capsulorhexis, as well as to pre-fragment the clouded lens of the eye in order to reduce the required ultrasonic energy to break up and remove the cataract. Sarasota’s Center For Sight the first ophthalmic practice in the nation to acquire this breakthrough technology and has since performed more than 500 refractive cataract surgeries using the laser – making Center For Sight the most experienced user of the LENSAR Laser in the country.

“This is the real deal,” says David W. Shoemaker, M.D., Center For Sight founder and Director of Cataract and Lens Replacement Surgery. “The LENSAR Laser has performed flawlessly each and every time. As a physician and surgeon, I am in awe of the genius of this technology.”

The LENSAR system is the world’s only computer-driven femtosecond cataract laser to provide a real 3-D image of the entire lens of the eye. The ultra precise imaging and biometric measurements ensure exact laser pulse placement. All the incisions made with the laser take less than 15 seconds to complete.

“The advances in ophthalmic surgery are nothing less than astounding. There is no other field of medicine that has progressed at such a dynamic pac
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. San Francisco Bath Salt Company Clears Air About Bath Salt Confusion – Zombies Beware!
2. FDA clears test developed in partnership with VCU researcher
3. No more lying about your age: Scientists can now gauge skin’s true age with new laser technique
4. Beachwood Hair Clinic Announces Laser Hair Removal Services
5. Laser-light testing of breast tumor fiber patterns helps show whose cancer is spreading
6. Studies Show Limits, Promise of Laser Removal of Tattoos
7. Laser treatment improves appearance in burn scars, study shows
8. Higher energies for laser-accelerated particles possible
9. Ultra-short laser pulses for science and industry
10. Screening for breast cancer without X-rays: Lasers and sound merge in promising diagnostic technique
11. Slicing mitotic spindle with lasers, nanosurgeons unravel old pole-to-pole theory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 The Rottenstein Law Group ... has created the Tylenol Lawsuit Information Center at ... users and those who are considering filing lawsuits. ... potentially cause severe liver damage, according to a 2009 ... In the “safety communication,” the FDA warned consumers against ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 ... have a great deal of control over their level ... their weight, yet far fewer are actually taking that ... International Food Information Council (IFIC) Foundation’s 2013 Food & ... of respondents say it’s possible to have “a great ...
(Date:5/23/2013)... Chicago, IL (PRWEB) May 23, 2013 ... the fifth anniversary of its popular and only free ... and a successful continuing resource for OCD sufferers, the ... anxiety, OCD, and related disorders. This allows group ... Therapy, and Exposure and Response Prevention. , “Participants in ...
(Date:5/23/2013)... (HealthDay News) -- Schools should ensure that kids ... each day to support their health and boost ... Although previous studies show 60 minutes ... and development, it,s estimated that only about 50 ... recommendation, according to the report from the Institute ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) ... as badly as methamphetamine or crack cocaine, a new ... ,meth mouth, or ,coke mouth, it is startling to ... less the same," said Dr. Mohamed Bassiouny, a professor ... Dentistry in Philadelphia. Methamphetamine, crack cocaine and soda ...
Breaking Medicine News(10 mins):Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3
... Scientific understanding and medical treatments for autism spectrum disorders ... but much remains to be done, say experts from ... of Philadelphia who published a scientific review of the ... by autism researchers throughout the world, and give our ...
... , BALTIMORE, Oct. 14 Lynn R. Chincheck, DDS, and ... breast cancer on Sunday, Oct. 18, as part of Baltimore,s ... participate by patients who have battled breast cancer, Team Chincheck ... , "After meeting several patients who have been affected by ...
... Advice Networks , the nation,s leading provider of physician ... track consumer purchase behavior, not just purchase intent, for ... their revenue and justify investments designed to capture market ... their health messages to purchase volume. To address this ...
... Almost a billion people across the planet do not have ... a mere $5 can give one person clean water for ... to doing good and supporting good in communities through a ... bringing clean and safe drinking water to people in developing ...
... Cardium Therapeutics (NYSE Amex: CXM ) today ... product candidate Excellagen(TM), a collagen-based topical gel for use ... in patients with chronic or non-chronic diabetic foot ulcers. ... study findings reported today from the Excellarate(TM) Phase 2b ...
... ... it will feature the latest developments in its advanced DuraHeart™ Left-Ventricular Assist System at ... October 17-21. , ... Ann Arbor, Mich. (PRWEB) -- Terumo Heart, Inc., a wholly owned subsidiary of ...
Cached Medicine News:Health News:Experts summarize state of the science in autism disorders 2Health News:Team Chincheck Goes Miles for Smiles 2Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 2Health News:Healthy Advice Networks Now Able to Track Consumer Purchase Behavior 3Health News:Tom's of Maine and charity: water Team Up to Fund Global Clean Water Projects With Instant, Mobile Donation Campaign 2Health News:Tom's of Maine and charity: water Team Up to Fund Global Clean Water Projects With Instant, Mobile Donation Campaign 3Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 2Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 3Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 4Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 5Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 6Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 7Health News:Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers 8Health News:DuraHeart™ Third-Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio-thoracic Surgery 2Health News:DuraHeart™ Third-Generation Left Ventricular Assist System Featured at 23rd Annual Meeting of the European Association for Cardio-thoracic Surgery 3
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation ... global medical technology company, today scheduled a conference call ... of fiscal year 2013, ended April 30, 2013. The ... May 30, 2013. The Company will report financial results ... the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... 23, 2013  The need to add tissue ... was highlighted prominently at the 108 th ... in San Diego.  According to SonaCare Medical, a ... (HIFU) technology, the need for image-guided technologies to ... to consider minimally invasive ablative treatments, was addressed ...
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... 17, 2007 - ProNAi Therapeutics,Inc., a biopharmaceutical ... based on DNA interference (DNAi), today,announced that ... demonstrated preclinical in vivo efficacy in,xenograft mice ... including curative,events for difficult-to-treat Burkitt's Lymphoma., Dr. ...
... April 17, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. announced ... 2 clinical trial of the triplet combination ... in the,first-line treatment of advanced non-small cell ... clinically significant,improvement in both progression-free survival and ...
Cached Medicine Technology:ProNAi Announces Preclinical Success for PNT2258 Therapeutic -,Curative Events in Xenograft Mice for Difficult-to-Treat,Non-Hodgkin's Lymphoma 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 3Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 4
... The Macula Plus® 5.5 ... observation of the optic ... Use it with your ... detecting choroidal neovascular membranes, ...
... iQ200 Automated Urine Microscopy Analyzer (iQ200) ... (APR) software to classify urine particles ... results. The iQ200 eliminates most technologist ... particle images by automating specimen preparation, ...
... is based on the C6 peptide antigen, a ... VlsE. This peptide has been shown to ... all of the antigenic reactivity of the whole ... C6 peptide is a sensitive and specific marker ...
First to USA-market, this revolutionary technology combines CBC and CRP analysis for stat results of 17 parameters within 4.5 minutes!...
Medicine Products: